The effects of acute catecholamine release by guanoxan upon the myocardial metabolism of the intact dog.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001786:Blood Glucose; D002245:Carbon Dioxide / Q000378:metabolism; D002247:Carbon Isotopes; D002395:Catecholamines / Q000378:metabolism*; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics; D007773:Lactates / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects; D010169:Palmitic Acids / Q000378:metabolism; D011773:Pyruvates / Q000378:metabolism; D012039:Regional Blood Flow / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects
D000959:Antihypertensive Agents; D001786:Blood Glucose; D002247:Carbon Isotopes; D002395:Catecholamines; D005230:Fatty Acids, Nonesterified; D007773:Lactates; D010169:Palmitic Acids; D011773:Pyruvates; D002245:Carbon Dioxide; D005947:Glucose